MedTrace Logo

Chlorproguanil/Dapsone Compared With Chloroquine and SP for Vivax Malaria

NCT00158561 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 750

Last updated 2017-01-12

No results posted yet for this study

Summary

To determine whether two cheap antifolates (chlorproguanil-dapsone and sulfadoxine-pyrimethamine) which work against falciparum malaria in this region are sufficiently effective against vivax malaria to be deployed in areas where diagnosis is poor and the burden of malaria is high, a randomised controlled trial of the three drugs is being undertaken comparing their efficacy in treating malaria.

Conditions

Interventions

DRUG

sulfadoxine-pyrimethamine and chlorproguanil-dapsone

Sponsors & Collaborators

  • HealthNet TPO

    collaborator OTHER

  • London School of Hygiene and Tropical Medicine

    lead OTHER

Principal Investigators

  • Christopher Whitty, FRCP · London School of Hygiene and Tropical Medicine

  • Mark Rowland, PhD · London School of Hygiene and Tropical Medicine

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29
Completion
2006-03-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00158561 on ClinicalTrials.gov